![]() |
|
|
Vol. 282, Issue 1, 355-362, 1997
Departments of
Pharmacology (C.A.P. and J.H.W.) and
Psychology
(J.H.W.), The University of Michigan Medical School, Ann Arbor,
Michigan
The antinociceptive and ventilatory effects of morphine and other
opioid agonists were determined in three rhesus monkeys during a period
of morphine maintenance, as well as before and after the chronic
exposure to morphine. Before the onset of the daily dosing regimen,
morphine increased tail-withdrawal latencies from 50°C water, with an
ED50 of 6.4 ± 2.1 mg/kg. Daily injection of 3.2 mg/kg
morphine produced a rightward displacement of the morphine
dose-response curve, increasing the ED50 of morphine to
28.4 ± 12.3 mg/kg. Doubling the daily morphine dose to 6.4 mg/kg
resulted in a further shift to the right of the dose-response curve of
morphine. After cessation of the daily dosing regimen, the morphine
dose-response curve for producing antinociceptive effects returned
toward baseline. The antinociceptive effects of the
kappa opioid agonist, ethylketazocine, were similar
during the period of daily exposure to morphine, and after cessation of
the daily dosing regimen. Before the onset of the daily dosing regimen,
morphine, ethylketazocine, fentanyl, butorphanol and nalbuphine
decreased ventilation in the presence of air or air mixed with
CO2. The baseline ED50 value of morphine for
decreasing minute volume in the presence of 5% CO2 was
2.9 ± 0.8 mg/kg. The ventilatory effects of morphine and other
mu opioid agonists tested were not attenuated during the
daily morphine-dosing regimen. After 40 weeks of daily injections of
3.2 mg/kg morphine, the ED50 of morphine for decreasing
minute volume in 5% CO2 was 2.3 ± 1.0 mg/kg, and
when the daily dose was doubled to 6.4 mg/kg morphine, the
ED50 of morphine was 1.5 ± 0.5 mg/kg. The ventilatory depressant effects of the daily injection 3.2 mg/kg morphine were also
unchanged during morphine maintenance. The differential development of
tolerance to the antinociceptive and ventilatory effects of morphine
demonstrates a separation of these two mu opioid agonist effects in rhesus monkeys.